Schedule 13G ownership disclosure
Integra LifeSciences Holdings Corp
Common Stock · CUSIP: 457985208
Event date: 2025-06-30
- Filing-level shares
- 3,379,401
- Percent of class
- 4.3%
- Morgan Stanley
Shares: 3,379,401 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000445
- Form type
- SCHEDULE 13G/A
- Filer
- INTEGRA LIFESCIENCES HOLDINGS CORP
- CIK
- CIK 917520
- Filed
- Aug 05, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership